These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26879635)

  • 1. Imaging synucleinopathies.
    Brooks DJ; Tambasco N
    Mov Disord; 2016 Jun; 31(6):814-29. PubMed ID: 26879635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
    Peelaerts W; Bousset L; Baekelandt V; Melki R
    Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synucleinopathy phenotypes.
    McCann H; Stevens CH; Cartwright H; Halliday GM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S62-7. PubMed ID: 24262191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology underlying clinical variability in patients with synucleinopathies.
    Halliday GM; Holton JL; Revesz T; Dickson DW
    Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
    Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
    Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy.
    Sevenich M; Honold D; Willuweit A; Kutzsche J; Mohrlüder J; Willbold D
    Neurochem Int; 2022 Dec; 161():105422. PubMed ID: 36252819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Smith R; Schöll M; Londos E; Ohlsson T; Hansson O
    Sci Rep; 2018 Mar; 8(1):4717. PubMed ID: 29549278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
    Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
    Barone DA; Henchcliffe C
    Clin Neurophysiol; 2018 Aug; 129(8):1551-1564. PubMed ID: 29883833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synucleinopathies: common features and hippocampal manifestations.
    Yang W; Yu S
    Cell Mol Life Sci; 2017 Apr; 74(8):1485-1501. PubMed ID: 27826641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles.
    Meade RM; Fairlie DP; Mason JM
    Mol Neurodegener; 2019 Jul; 14(1):29. PubMed ID: 31331359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.